These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11420336)

  • 1. BSAC standardized disc susceptibility testing method.
    Andrews JM;
    J Antimicrob Chemother; 2001 Jul; 48 Suppl 1():43-57. PubMed ID: 11420336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BSAC standardized disc susceptibility testing method (version 10).
    Andrews JM; Howe RA;
    J Antimicrob Chemother; 2011 Dec; 66(12):2726-57. PubMed ID: 21921076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of the BSAC standardized method of disc diffusion testing.
    Andrews JM
    J Antimicrob Chemother; 2001 Jul; 48 Suppl 1():29-42. PubMed ID: 11420335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BSAC standardized disc susceptibility testing method (version 11).
    Howe RA; Andrews JM;
    J Antimicrob Chemother; 2012 Dec; 67(12):2783-4. PubMed ID: 23095231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BSAC standardized disc susceptibility testing method (version 7).
    Andrews JM;
    J Antimicrob Chemother; 2008 Aug; 62(2):256-78. PubMed ID: 18474513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.
    Brown DF; Wootton M; Howe RA
    J Antimicrob Chemother; 2016 Jan; 71(1):3-5. PubMed ID: 26377864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
    J Antimicrob Chemother; 2003 Dec; 52(6):925-30. PubMed ID: 14585864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints.
    Gosden PE; Andrews JM; Bowker KE; Holt HA; MacGowan AP; Reeves DS; Sunderland J; Wise R
    J Antimicrob Chemother; 1998 Aug; 42(2):161-9. PubMed ID: 9738833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of routine disc susceptibility testing by the British Society for Antimicrobial Chemotherapy (BSAC) method.
    Potz NA; Mushtaq S; Johnson AP; Henwood CJ; Walker RA; Varey E; Warner M; James D; Livermore DM
    J Antimicrob Chemother; 2004 May; 53(5):729-38. PubMed ID: 15056636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of media available for testing the susceptibility of Pseudomonas aeruginosa by BSAC methodology.
    Andrews J; Walker R; King A
    J Antimicrob Chemother; 2002 Oct; 50(4):479-86. PubMed ID: 12356791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BSAC standardized disc susceptibility testing method (version 5).
    Andrews JM;
    J Antimicrob Chemother; 2006 Sep; 58(3):511-29. PubMed ID: 16840429
    [No Abstract]   [Full Text] [Related]  

  • 12. BSAC standardized disc susceptibility testing method (version 6).
    Andrews JM;
    J Antimicrob Chemother; 2007 Jul; 60(1):20-41. PubMed ID: 17460026
    [No Abstract]   [Full Text] [Related]  

  • 13. BSAC standardized disc susceptibility testing method (version 8).
    Andrews JM;
    J Antimicrob Chemother; 2009 Sep; 64(3):454-89. PubMed ID: 19587067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK.
    Hope R; Mushtaq S; James D; Pllana T; Warner M; Livermore DM;
    J Antimicrob Chemother; 2010 Dec; 65(12):2602-9. PubMed ID: 20930043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes.
    Reynolds R; Hope R; Williams L;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii15-28. PubMed ID: 18819976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSAC standardized disc susceptibility testing method (version 3).
    Andrews JM
    J Antimicrob Chemother; 2004 May; 53(5):713-28. PubMed ID: 15028662
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposed disc zone breakpoints for doripenem for use with the BSAC disc susceptibility testing method.
    Hope R; Pllana T; Warner M; Livermore DM
    J Antimicrob Chemother; 2010 Jul; 65(7):1547-8. PubMed ID: 20483980
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
    Matuschek E; Brown DF; Kahlmeter G
    Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of EUCAST zone diameter breakpoints against reference broth microdilution.
    Bengtsson S; Bjelkenbrant C; Kahlmeter G
    Clin Microbiol Infect; 2014 Jun; 20(6):O353-60. PubMed ID: 24118469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.